Class information for:
Level 1: CISPLATIN RESISTANCE//RAT OVARIAN TUMOR CELL LINES//TCRP1

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
14457 768 38.1 79%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
5 4 CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY 1745167
489 3       CISPLATIN//STABILITY CONSTANTS//JOURNAL OF INORGANIC BIOCHEMISTRY 23107
1065 2             CISPLATIN//NEPHROTOXICITY//PLATINUMII COMPLEXES 9996
14457 1                   CISPLATIN RESISTANCE//RAT OVARIAN TUMOR CELL LINES//TCRP1 768

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CISPLATIN RESISTANCE authKW 485163 9% 17% 71
2 RAT OVARIAN TUMOR CELL LINES authKW 165657 1% 83% 5
3 TCRP1 authKW 159033 1% 100% 4
4 CISPLATIN authKW 141537 25% 2% 190
5 DWA2114R authKW 124241 1% 63% 5
6 APHIDICOLIN GLYCINATE authKW 79516 0% 100% 2
7 CIS DIAMMINE DICHLOROPLATINUMII authKW 79516 0% 100% 2
8 DAMAGE RECOGNITION PROTEIN authKW 79516 0% 100% 2
9 DDP RESISTANCE authKW 79516 0% 100% 2
10 LIPOSOMAL VALINOMYCIN authKW 79516 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 13439 67% 0% 518
2 Pharmacology & Pharmacy 743 20% 0% 154
3 Biochemistry & Molecular Biology 47 11% 0% 87
4 Cell Biology 47 6% 0% 47
5 Toxicology 46 3% 0% 24
6 Medicine, Research & Experimental 17 3% 0% 23
7 Biophysics 14 3% 0% 21
8 Obstetrics & Gynecology 13 2% 0% 16
9 Otorhinolaryngology 2 1% 0% 6
10 Chemistry, Medicinal 2 1% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BILL WALSH CANC S 44718 1% 19% 6
2 ANALYTICON AG 39758 0% 100% 1
3 ARBEITSGRP PADIAT NEUROONKOL 39758 0% 100% 1
4 BIJOVET 39758 0% 100% 1
5 BIL WALSH CANC S 39758 0% 100% 1
6 CANC 0812 39758 0% 100% 1
7 CLCC F BACLESSEEA 1772 39758 0% 100% 1
8 CNRSFRE 2618 39758 0% 100% 1
9 COMITE UROGYNECOL ONCOL 39758 0% 100% 1
10 DANIEL DEN HOED KLINK 39758 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER CHEMOTHERAPY AND PHARMACOLOGY 10937 6% 1% 45
2 CANCER COMMUNICATIONS 6229 1% 4% 4
3 ANTI-CANCER DRUGS 5868 3% 1% 22
4 CANCER RESEARCH 5835 10% 0% 76
5 ANTICANCER RESEARCH 4553 6% 0% 47
6 JAPANESE JOURNAL OF CANCER RESEARCH 3218 2% 0% 17
7 INTERNATIONAL JOURNAL OF ONCOLOGY 2372 3% 0% 24
8 EXPERIMENTAL ONCOLOGY 2354 1% 1% 6
9 ONCOLOGY REPORTS 2277 3% 0% 24
10 BIOCHEMICAL PHARMACOLOGY 1897 4% 0% 30

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CISPLATIN RESISTANCE 485163 9% 17% 71 Search CISPLATIN+RESISTANCE Search CISPLATIN+RESISTANCE
2 RAT OVARIAN TUMOR CELL LINES 165657 1% 83% 5 Search RAT+OVARIAN+TUMOR+CELL+LINES Search RAT+OVARIAN+TUMOR+CELL+LINES
3 TCRP1 159033 1% 100% 4 Search TCRP1 Search TCRP1
4 CISPLATIN 141537 25% 2% 190 Search CISPLATIN Search CISPLATIN
5 DWA2114R 124241 1% 63% 5 Search DWA2114R Search DWA2114R
6 APHIDICOLIN GLYCINATE 79516 0% 100% 2 Search APHIDICOLIN+GLYCINATE Search APHIDICOLIN+GLYCINATE
7 CIS DIAMMINE DICHLOROPLATINUMII 79516 0% 100% 2 Search CIS+DIAMMINE+DICHLOROPLATINUMII Search CIS+DIAMMINE+DICHLOROPLATINUMII
8 DAMAGE RECOGNITION PROTEIN 79516 0% 100% 2 Search DAMAGE+RECOGNITION+PROTEIN Search DAMAGE+RECOGNITION+PROTEIN
9 DDP RESISTANCE 79516 0% 100% 2 Search DDP+RESISTANCE Search DDP+RESISTANCE
10 LIPOSOMAL VALINOMYCIN 79516 0% 100% 2 Search LIPOSOMAL+VALINOMYCIN Search LIPOSOMAL+VALINOMYCIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 BERETTA, GL , GATTI, L , TINELLI, S , CORNA, E , COLANGELO, D , ZUNINO, F , PEREGO, P , (2004) CELLULAR PHARMACOLOGY OF CISPLATIN IN RELATION TO THE EXPRESSION OF HUMAN COPPER TRANSPORTER CTR1 IN DIFFERENT PAIRS OF CISPLATIN-SENSITIVE AND -RESISTANT CELLS.BIOCHEMICAL PHARMACOLOGY. VOL. 68. ISSUE 2. P. 283-291 28 68% 42
2 SHELLARD, SA , HOSKING, LK , HILL, BT , (1991) ANOMALOUS RELATIONSHIP BETWEEN CISPLATIN SENSITIVITY AND THE FORMATION AND REMOVAL OF PLATINUM-DNA ADDUCTS IN 2 HUMAN OVARIAN-CARCINOMA CELL-LINES INVITRO.CANCER RESEARCH. VOL. 51. ISSUE 17. P. 4557-4564 47 64% 43
3 HALL, MD , OKABE, M , SHEN, DW , LIANG, XJ , GOTTESMAN, MM , (2008) THE ROLE OF CELLULAR ACCUMULATION IN DETERMINING SENSITIVITY TO PLATINUM-BASED CHEMOTHERAPY.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 48. ISSUE . P. 495-535 49 26% 199
4 JOHNSON, SW , LAUB, PB , BEESLEY, JS , OZOLS, RF , HAMILTON, TC , (1997) INCREASED PLATINUM-DNA DAMAGE TOLERANCE IS ASSOCIATED WITH CISPLATIN RESISTANCE AND CROSS-RESISTANCE TO VARIOUS CHEMOTHERAPEUTIC AGENTS IN UNRELATED HUMAN OVARIAN CANCER CELL LINES.CANCER RESEARCH. VOL. 57. ISSUE 5. P. 850-856 31 66% 114
5 JOHNSON, SW , SHEN, DW , PASTAN, I , GOTTESMAN, MM , HAMILTON, TC , (1996) CROSS-RESISTANCE, CISPLATIN ACCUMULATION, AND PLATINUM-DNA ADDUCT FORMATION AND REMOVAL IN CISPLATIN-SENSITIVE AND -RESISTANT HUMAN HEPATOMA CELL LINES.EXPERIMENTAL CELL RESEARCH. VOL. 226. ISSUE 1. P. 133-139 30 71% 38
6 HILL, BT , SHELLARD, SA , HOSKING, LK , DEMPKE, WCM , FICHTINGERSCHEPMAN, AMJ , TONE, T , SCANLON, KJ , WHELAN, RDH , (1992) CHARACTERIZATION OF A CISPLATIN-RESISTANT HUMAN OVARIAN-CARCINOMA CELL-LINE EXPRESSING CROSS-RESISTANCE TO 5-FLUOROURACIL BUT COLLATERAL SENSITIVITY TO METHOTREXATE.CANCER RESEARCH. VOL. 52. ISSUE 11. P. 3110-3118 41 62% 27
7 LOS, G , MUGGIA, FM , (1994) PLATINUM RESISTANCE - EXPERIMENTAL AND CLINICAL STATUS.HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. VOL. 8. ISSUE 2. P. 411 -429 46 49% 12
8 GATELY, DP , HOWELL, SB , (1993) CELLULAR ACCUMULATION OF THE ANTICANCER AGENT CISPLATIN - A REVIEW.BRITISH JOURNAL OF CANCER. VOL. 67. ISSUE 6. P. 1171-1176 22 67% 385
9 AKIYAMA, S , CHEN, ZS , SUMIZAWA, T , FURUKAWA, T , (1999) RESISTANCE TO CISPLATIN.ANTI-CANCER DRUG DESIGN. VOL. 14. ISSUE 2. P. 143 -151 37 42% 98
10 TIMMERBOSSCHA, H , MULDER, NH , DEVRIES, EGE , (1992) MODULATION OF CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE - A REVIEW.BRITISH JOURNAL OF CANCER. VOL. 66. ISSUE 2. P. 227-238 43 39% 166

Classes with closest relation at Level 1


Rank Class id link
1 5887 SATRAPLATIN//JM216//PLATINUM BASED DRUG
2 14435 BUTHIONINE SULFOXIMINE//L 2 OXOTHIAZOLIDINE 4 CARBOXYLATE//5 OXO L PROLINASE
3 879 TRANSPLATIN//TRANSPLATINUM//BBR3464
4 28842 L HISTIDINOL//ZILASCORBH 2//SPARSOMYCIN
5 30430 DIAZENES//DIAZENECARBOXAMIDE//DIAZENEDICARBOXAMIDES
6 13007 ERCC1//RRM1//MED OVARIAN CANC SECT
7 22025 DRUG EFFECT ON BRAIN//PT 191 CISPLATIN//LIPOPLATIN TM
8 35925 BIOPHYS CYTOCHEM//C13 OVARIAN CELL//HOSP ALMIRANTE NEF MED NEFROL
9 3335 CISPLATIN//NEPHROTOXICITY//CISPLATIN NEPHROTOXICITY
10 20094 MELPHALAN//CHLORAMBUCIL//PREDNIMUSTINE

Go to start page